Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II - ScienceDirect
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II - ScienceDirect
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Elecsys® PIVKA-II
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
Clinical course of the patient. a Tumor markers (AFP, PIVKA-II)... | Download Scientific Diagram
Levels of AFP and PIVKA-II in Different Types of Liver Diseases A B | Download Scientific Diagram
Clinical Utility of Tumor Markers
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma | Scientific Reports
pivka_ii_pair_recommendations_1.jpg
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma | PLOS ONE
The value of PIVKA-Ⅱ versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma - ScienceDirect
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment | PLOS ONE
